blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0944597

EP0944597 - METALLOPROTEINASE INHIBITORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.10.2003
Database last updated on 03.10.2024
Most recent event   Tooltip03.10.2003Application deemed to be withdrawnpublished on 19.11.2003  [2003/47]
Applicant(s)For all designated states
BRITISH BIOTECH PHARMACEUTICALS LIMITED
Watlington Road Cowley
Oxford, OX4 5LY / GB
[N/P]
Former [1999/39]For all designated states
BRITISH BIOTECH PHARMACEUTICALS LIMITED
Watlington Road
Cowley Oxford, OX4 5LY / GB
Inventor(s)01 / FLOYD, Christopher, David
British Biotech Phar. Ltd., Watlington Road
Cowley, Oxford OX4 5LY / GB
[1999/39]
Representative(s)Walls, Alan James, et al
British Biotech Pharmaceuticals Ltd.
Watlington Road
Oxford
OX4 5LY / GB
[N/P]
Former [1999/39]Walls, Alan James, et al
British Biotech Pharmaceuticals Ltd., Watlington Road
Oxford OX4 5LY / GB
Application number, filing date97945960.927.11.1997
[1999/39]
WO1997GB03258
Priority number, dateGB1996002481728.11.1996         Original published format: GB 9624817
[1999/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9823588
Date:04.06.1998
Language:EN
[1998/22]
Type: A1 Application with search report 
No.:EP0944597
Date:29.09.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 04.06.1998 takes the place of the publication of the European patent application.
[1999/39]
Search report(s)International search report - published on:EP04.06.1998
ClassificationIPC:C07D209/48, C07D401/12, C07K5/06, A61K31/40, A61K38/00
[1999/39]
CPC:
C07K5/06078 (EP); A61P19/00 (EP); A61P43/00 (EP);
C07K5/0606 (EP); A61K38/00 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1999/39]
TitleGerman:METALLOPROTEINASE-HEMMER[1999/39]
English:METALLOPROTEINASE INHIBITORS[1999/39]
French:INHIBITEURS DE METALLOPROTEINASES[1999/39]
Entry into regional phase21.05.1999National basic fee paid 
21.05.1999Designation fee(s) paid 
21.05.1999Examination fee paid 
Examination procedure19.05.1998Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.05.1999Examination requested  [1999/39]
02.01.2003Despatch of a communication from the examining division (Time limit: M04)
13.05.2003Application deemed to be withdrawn, date of legal effect  [2003/47]
17.06.2003Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2003/47]
Fees paidRenewal fee
10.11.1999Renewal fee patent year 03
18.10.2000Renewal fee patent year 04
17.10.2001Renewal fee patent year 05
12.10.2002Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[PX]WO9703783  (BRITISH BIOTECH PHARM [GB], et al) [PX] 1,21 * examples 21,22; claims 1,20 *;
 [DX]WO9611209  (CHIROSCIENCE LTD [GB]) [DX] 1,21 * claims 1,17 *;
 [X]WO9635712  (CHIROSCIENCE LTD [GB]) [X] 1,21 * claims 1,20 *;
 [PX]WO9738007  (CHIROSCIENCE LTD [GB]) [PX] 1,21 * claims 1,5 *;
 [AD]WO9513289  (CHIROSCIENCE LTD [GB], et al) [AD] 1,21 * claims 1,4 *;
 [AD]  - R. D. GRAY ET AL., BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (1981), vol. 101, no. 4, pages 1251 - 8, XP002058265

DOI:   http://dx.doi.org/10.1016/0006-291X(81)91582-5
 [AD]  - K. T. CHAPMAN ET AL., JOURNAL OF MEDICINAL CHEMISTRY, (1993), vol. 36, pages 4293 - 4301, XP002058266

DOI:   http://dx.doi.org/10.1021/jm00078a019
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.